Larson Financial Group’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$371 Buy
14
+8
+133% +$207 ﹤0.01% 3638
2026
Q2
$157 Hold
6
– – ﹤0.01% 3621
2026
Q1
$150 Hold
6
– – ﹤0.01% 3485
2025
Q4
$158 Buy
+6
New +$131 ﹤0.01% 3307

Other funds holding ZYME

Larson Financial Group's ZYME Position: Q3 2026 in Review

Larson Financial Group increased its Zymeworks (ZYME) stake by 133% in Q3 2026, buying an estimated $207 and bringing the position to 14 shares worth $371. The position accounts for ﹤0.01% of the portfolio, ranked #3638.

Larson Financial Group first reported a position in ZYME in Q4 2025 and has held it in 4 quarters since. 68 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.

  • Larson Financial Group held 14 shares of Zymeworks worth $371 as of Q3 2026.
  • Larson Financial Group bought 8 Zymeworks shares in Q3 2026, an estimated $207.
  • Zymeworks made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3638 holding.
  • Larson Financial Group first reported a position in Zymeworks in Q4 2025 and has held it in 4 quarters since.
  • 68 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.